Showing results (191-200 of 263) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trialD F Bajorin, J A McCaffrey, S Hilton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasmsH I Scher, A Sarkis, V Reuter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancerM J Zelefsky, W K Kelly, H I Scher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumorsR J Motzer, D F Bajorin, L H Schwartz, et al.Oncology (Williston Park, N.Y.)|April 1, 1997
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of CancerG Giaccone, P E Postmus, T A Splinter, et al.Journal of Clinical Epidemiology|January 1, 1988
Day hospital as an alternative to inpatient care for cancer patients: a random assignment trialV Mor, M Z Stalker, R Gralla, et al.Cancer|August 1, 1984
Estrogen, progesterone, and androgen-binding sites in renal cell carcinoma. Observations obtained in Phase II trial of flutamideT Ahmed, P Benedetto, A Yagoda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory diseaseH I Scher, T Curley, N Geller, et al.European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trialP E Postmus, G Scagliotti, H J Groen, et al.Pageof 27